BLACK mobile logo

united states

Judge approves $7.25bn settlement for Roundup weedkiller cancer claims

November 21, 2026

A Missouri judge has approved Bayer's $7. 25 billion settlement to resolve legal claims from people who allege the company's Roundup weedkiller caused them to develop non-Hodgkin lymphoma. Individual payments will range from $10,000 to $165,000 based on usage frequency, diagnosis timing, and illness severity, with Bayer making annual contributions to the settlement fund for up to 21 years.

Who is affected

  • Roundup users diagnosed with non-Hodgkin lymphoma (current and future cases)
  • Bayer (German biotech company)
  • Monsanto (original developer of Roundup, acquired by Bayer)
  • Some attorneys who objected to the settlement amounts
  • Judge Timothy Boyer (presiding judge in Missouri)

What action is being taken

  • Bayer is making annual payments into a settlement fund for up to 21 years
  • The settlement is providing payments ranging from $10,000 to $165,000 to participants
  • Judge Timothy Boyer has approved the $7.25 billion settlement

Why it matters

  • This settlement represents one of the largest product liability resolutions in US history and addresses widespread health concerns about a commonly used herbicide. The case has significant implications for corporate accountability in the agricultural chemical industry, particularly regarding products that regulatory agencies have disputed over their safety. With Bayer having now spent over $17 billion total on Roundup litigation, the settlement demonstrates the substantial financial and legal risks companies face when their products are alleged to cause serious health conditions, even when they maintain the products are safe.

What's next

  • No explicit next steps stated in the article

Read full article from source: BBC

Judge approves $7.25bn settlement for Roundup weedkiller cancer claims